Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 2/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.50 |
| ▸ | HTT | P42858 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | CYP17A1 | P05093 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | LTA4H | P09960 | 2/20 | 0.48 |
| ▸ | MAOB | P27338 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | ATM | Q13315 | 1/20 | 0.46 |
| ▸ | CLK4 | Q9HAZ1 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28827825 | 0.80 | CHRNA7 (0.57) | MAPTSMN1; SMN2NPC1RAB9AKDM4E | |
| SCHEMBL6059611 | 0.79 | LTA4H (0.71) | SMN1; SMN2TSHRALOX15CYP17A1LTA4H | |
| SCHEMBL22451382 | 0.79 | LTA4H (0.71) | SMN1; SMN2TSHRALOX15CYP17A1LTA4H | |
| SCHEMBL15896952 | 0.79 | CLK4 (0.61) | MAPK1MAPTSMN1; SMN2TDP1MEN1 | |
| SCHEMBL2876553 | 0.79 | CLK4 (0.61) | MAPK1MAPTSMN1; SMN2TDP1MEN1 | |
| SCHEMBL25986535 | 0.79 | LTA4H (0.71) | SMN1; SMN2TSHRALOX15CYP17A1LTA4H | |
| SCHEMBL1976140 | 0.79 | CLK4 (0.48) | L3MBTL1MAPK1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL15894215 | 0.77 | MAOB (0.49) | L3MBTL1MAPK1MAPTSMN1; SMN2TDP1 | |
| SCHEMBL28827834 | 0.77 | CHRNA7 (0.59) | L3MBTL1MAPTSMN1; SMN2KMT2ANPC1 | |
| SCHEMBL15894207 | 0.77 | MAOB (0.49) | L3MBTL1MAPK1MAPTSMN1; SMN2TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6057048-A | Electroluminescent (EL) devices | XEROX CORPORATION (US) | 2000-05-02 | — | — | US | claimed |
| US-9085729-B2 | Blue emitters for use in organic electroluminescence devices | LG DISPLAY CO., LTD. (KR) | 2015-07-21 | — | — | US | disclosed |
| EP-1669428-B1 | Organic electroluminescent devices | LG DISPLAY CO LTD (KR) | 2013-07-24 | — | — | EP | disclosed |
| US-7638206-B2 | Bifunctional compounds and OLED using the same | LG DISPLAY CO., LTD. (KR) | 2009-12-29 | — | — | US | disclosed |
| US-7402346-B2 | Organic electroluminescent devices | LG. PHILIPS LCD CO., LTD. (KR) | 2008-07-22 | — | — | US | disclosed |
| US-20070141390-A1 | Bifunctional compounds and OLED using the same | LG.PHILIPS LCD CO., LTD. (KR) | 2007-06-21 | — | — | US | disclosed |
| EP-1669428-A1 | Organic electroluminescent devices | L.G. Philips LCD Co., Ltd. (KR) | 2006-06-14 | — | — | EP | disclosed |
| US-20060121311-A1 | Organic electroluminescent devices | XEROX CORPORATION. | 2006-06-08 | — | — | US | disclosed |
| US-20050175857-A1 | Element including fluorescent 1,1'-binaphthyl derivative; uniform luminescence, saturated color; thermal stability; performance; vacuum deposition thin films; enhanced charge transporting, reduced driving voltage | XEROX CORPORATION (US) | 2005-08-11 | — | — | US | disclosed |
| US-6562485-B2 | Electroluminescent (EL) devices | XEROX CORPORATION | 2003-05-13 | — | — | US | disclosed |
| US-20030044646-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2003-03-06 | — | — | US | disclosed |
| US-6479172-B2 | PERFORMANCE, THERMOSTABILITY | XEROX CORPORATION | 2002-11-12 | — | — | US | disclosed |
| US-20020132134-A1 | Electroluminescent (EL) devices | XEROX CORPORATION | 2002-09-19 | — | — | US | disclosed |
| US-6057048-A | Electroluminescent (EL) devices | XEROX CORPORATION (US) | 2000-05-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060121311-A1 | Organic electroluminescent devices | KCNH3, GLUL, ARGLU1 | L3MBTL1 750/4885MAPK1 1280/4885MAPT 4276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.